Description
Cerebrolysin is a peptide-based formulation composed of a broad range of small protein fragments. It acts as a neurotrophic agent, meaning it supports the growth, survival, and repair of neurons. By stimulating key signaling pathways, such as those linked to brain-derived neurotrophic factor (BDNF), it fosters neuroplasticity, helping neurons form new connections. It is believed to enhance cognitive function by promoting learning, memory, and resilience in the face of cellular stress. In addition, it helps protect neurons by reducing oxidative stress, balancing neurotransmitter activity, and supporting synaptic strength. Altogether, it acts as a restorative agent for brain health, fostering improved cognition, neural resilience, and overall mental function.
Cerebrolysin Research Details
Cerebrolysin is a peptide-based mixture that has been studied in neurobiology and clinical literature for neurotrophic and neuroprotective properties. Research discusses BDNF/NGF-like signaling concepts, neuroplasticity, stroke/TBI/cognitive models, and cell-survival pathways.
99%+ target purity or lot-specific COA value
Porcine-brain-derived peptide mixture; lot identity by COA
Lyophilized research material unless otherwise specified by COA
Research use only
Research Background
Peptide mixture studied as a neurotrophic-factor-mimetic preparation affecting neuronal survival, plasticity, oxidative stress, and synaptic biology models. Key OneBio research contexts include neurotrophic signaling research, neuronal survival assays, neuroplasticity models, and oxidative-stress studies.
Specifications
| Compound | Cerebrolysin |
| SKU / Product | cerebrolysin |
| Molecular Weight | Mixture of low-molecular-weight peptides; verify by COA |
| Formula / Classification | Mixture; verify by COA |
| Database / Identity Note | Complex peptide mixture; verify by COA |
| Storage | -4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol |
Quality Verification
Each batch should be reviewed against its Certificate of Analysis, including identity confirmation, purity method, mass/sequence or component confirmation, appearance, and lot-specific handling notes. Blend products should be checked against component-ratio documentation where available.
Laboratory Preparation
Prepare only inside a qualified laboratory using validated solvent choice, concentration, sterility, and storage protocols. For lyophilized peptides, use sterile deionized water or bacteriostatic water when appropriate for the research protocol, mix gently, maintain cold-chain handling, and avoid repeated freeze-thaw cycles.
Product-Specific Q&A
What is Cerebrolysin used for in research?
Cerebrolysin is used as a research material for neurotrophic signaling research, neuronal survival assays, neuroplasticity models, and oxidative-stress studies. It is not offered for diagnostic, therapeutic, clinical, veterinary, or human-use applications.
What mechanism is most relevant for Cerebrolysin?
Peptide mixture studied as a neurotrophic-factor-mimetic preparation affecting neuronal survival, plasticity, oxidative stress, and synaptic biology models.
How should Cerebrolysin identity and purity be verified?
Use the lot-specific Certificate of Analysis to confirm identity, purity, mass/sequence or component profile, and any method-specific data such as LC-MS/HPLC. Technical values on this page are research references and should be checked against the delivered lot.
What storage conditions apply to Cerebrolysin?
-4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol. Keep sealed, dry, protected from light, and avoid repeated freeze-thaw cycles after preparation.
References
- PMID 26083192: Cerebrolysin for acute ischaemic stroke. The Cochrane database of systematic reviews 2015.
- PMID 19848437: Cerebrolysin: a review of its use in dementia. Drugs & aging 2009.
- PMID 28430363: Cerebrolysin for acute ischaemic stroke. The Cochrane database of systematic reviews 2017.

Reviews
There are no reviews yet.